Connection

Laurens Liesenborghs to Interleukin 1 Receptor Antagonist Protein

Back to Details
This is a "connection" page, showing publications Laurens Liesenborghs has written about Interleukin 1 Receptor Antagonist Protein.
Laurens Liesenborghs
Connection Strength
0.029
Interleukin 1 Receptor Antagonist Protein
  1. A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study. Trials. 2020 Dec 09; 21(1):1005.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.